Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: NCR Q3 Earnings

NCR (NYSE:NCR) reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings NCR beat their estimated earnings by 7.81%, which did not surprise analysts.
byBenzinga Insights
October 26, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

NCR (NYSE:NCR) reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

NCR beat their estimated earnings by 7.81%, which did not surprise analysts.

Revenue was up $312,000,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0, which was followed by a 8.94% drop in the share price the next day.

Here’s a look at NCR’s past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate 0.62 0.47 0.62 0.39
EPS Actual 0.62 0.51 0.59 0.54
Revenue Estimate 1.61B 1.54B 1.62B 1.55B
Revenue Actual 1.68B 1.54B 1.63B 1.59B

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Aldeyra Therapeutics Earnings Preview

By Benzinga Insights
Today, 3:23 AM
Aldeyra Therapeutics (NASDAQ:ALDX) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate that Aldeyra Therapeutics will report an earnings per share (EPS) of $-0.28.

ALDX

Read More

Earnings Preview: ObsEva

By Benzinga Insights
Today, 3:23 AM
ObsEva (NASDAQ:OBSV) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that ObsEva will report an earnings per share (EPS) of $-0.20.

OBSV